Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference2%

- Check26 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new version release with no additional substantive content changes described.SummaryDifference0.0%

- Check41 days agoChange DetectedLocations changed: 180 → 177 (4 deletions, 1 addition) with a new Wenzhou entry and new affiliation; metadata updated to revision v3.0.2 in September 2025.SummaryDifference4%

- Check48 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility locations across various countries, while also removing several previously listed locations. Notably, the names of cities and countries have been retained or replaced, ensuring the core content remains relevant.SummaryDifference19%

- Check62 days agoChange DetectedThe page has updated the number of study locations from 181 to 180 and has added specific dates related to the study, including a new completion date of August 19, 2025.SummaryDifference1.0%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.